Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy

References

• YueF, XiaK, WeiL, et al. Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats. J Gastroenterol Hepatol. 2020. doi:10.1111/jgh.15005
   PubMed Web of Science ®Google Scholar
• WongSW, ChanWK. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol. 2020;39(1):1–8. doi:10.1007/s12664-020-01018-x32152903
   PubMed Web of Science ®Google Scholar
• MussoG, GambinoR, CassaderM, PaganoG. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617–649. doi:10.3109/07853890.2010.51862321039302
   PubMed Web of Science ®Google Scholar
• SoderbergC, StalP, AsklingJ, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51(2):595–602. doi:10.1002/hep.2331420014114
   PubMed Web of Science ®Google Scholar
• PanX, WangP, LuoJ, et al. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients. Endocrine. 2015;48(3):834–847. doi:10.1007/s12020-014-0384-x25138963
   PubMed Web of Science ®Google Scholar
• BruntEM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7(4):195–203. doi:10.1038/nrgastro.2010.2120195271
   PubMed Web of Science ®Google Scholar
• LiuS, HuangT, LiuR, et al. Spermidine suppresses development of experimental abdominal aortic aneurysms. J Am Heart Assoc. 2020;9(8):e014757. doi:10.1161/JAHA.119.01475732308093
   PubMed Web of Science ®Google Scholar
• KhambuB, YanS, HudaN, LiuG, YinXM. Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. Liver Res. 2018;2(3):112–119. doi:10.1016/j.livres.2018.09.00431123622
   PubMedGoogle Scholar
• StacchiottiA, GrossiI, Garcia-GomezR, et al. Melatonin effects on non-alcoholic fatty liver disease are related to microRNA-34a-5p/Sirt1 axis and autophagy. Cells. 2019;8(9):1053. doi:10.3390/cells8091053
   PubMed Web of Science ®Google Scholar
• ZhangL, YaoZ, JiG. Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy. Front Pharmacol. 2018;9:1459. doi:10.3389/fphar.2018.0145930618753
   PubMed Web of Science ®Google Scholar
• TongW, JuL, QiuM, et al. Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3-FOXO3a pathway. Hepatol Res. 2016;46(9):933–943. doi:10.1111/hepr.1263426666995
   PubMed Web of Science ®Google Scholar
• ZhangHA, YangXY, XiaoYF. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochem Biophys Res Commun. 2016;474(2):364–370. doi:10.1016/j.bbrc.2016.04.11127109475
   PubMed Web of Science ®Google Scholar
• KamikuboR, KaiK, Tsuji-NaitoK, AkagawaM. β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. Mol Nutr Food Res. 2016;60(10):2228–2242. doi:10.1002/mnfr.20160019727234712
   PubMed Web of Science ®Google Scholar
• YouB, DunY, ZhangW, et al. Anti-insulin resistance effects of salidroside through mitochondrial quality control. J Endocrinol. 2020;244:383–393.31794423
   PubMed Web of Science ®Google Scholar
• JagerS, HandschinC, St-PierreJ, SpiegelmanBM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A. 2007;104(29):12017–12022. doi:10.1073/pnas.070507010417609368
   PubMed Web of Science ®Google Scholar
• ShinojimaN, YokoyamaT, KondoY, KondoS. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy. 2007;3(6):635–637. doi:10.4161/auto.491617786026
   PubMed Web of Science ®Google Scholar
• ZhouT, YeL, BaiY, et al. Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: a novel curcumin analog. PLoS One. 2014;9(9):e107876. doi:10.1371/journal.pone.010787625268357
   PubMed Web of Science ®Google Scholar
• FujitaN, ItohT, OmoriH, FukudaM, NodaT, YoshimoriT. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell. 2008;19(5):2092–2100. doi:10.1091/mbc.e07-12-125718321988
   PubMed Web of Science ®Google Scholar
• YuS, GongL-S, LiN-F, PanY-F, ZhangL. Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways. Biomed Pharmacother. 2018;97:213–224. doi:10.1016/j.biopha.2017.10.05929091869
   PubMed Web of Science ®Google Scholar
• ZhangHT, WuJ, WenM, SuLJ, LuoH. Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/t-Bid mitochondrial pathway. J Asian Nat Prod Res. 2012;14(7):626–633. doi:10.1080/10286020.2012.68215222575016
   PubMed Web of Science ®Google Scholar
• ZhangHT, LuoH, WuJ, et al. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol. 2010;16(27):3377–3384. doi:10.3748/wjg.v16.i27.337720632439
   PubMed Web of Science ®Google Scholar
• KongY, FengZ, ChenA, et al. The natural flavonoid galangin elicits apoptosis, pyroptosis, and autophagy in glioblastoma. Front Oncol. 2019;9:942. doi:10.3389/fonc.2019.0094231612107
   PubMed Web of Science ®Google Scholar
• LiR, GuoE, YangJ, et al. 1,25(OH)2 D3 attenuates hepatic steatosis by inducing autophagy in mice. Obesity. 2017;25(3):561–571. doi:10.1002/oby.2175728145056
   PubMed Web of Science ®Google Scholar
• LiM, MengX, XuJ, et al. GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway. Sci Rep. 2016;6:25237. doi:10.1038/srep2523727121981
   PubMed Web of Science ®Google Scholar
• ChienST, ShiMD, LeeYC, TeCC, ShihYW. Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells. Cancer Cell Int. 2015;15:15. doi:10.1186/s12935-015-0168-225698902
   PubMed Web of Science ®Google Scholar
• WangX, GongG, YangW, LiY, JiangM, LiL. Antifibrotic activity of galangin, a novel function evaluated in animal liver fibrosis model. Environ Toxicol Pharmacol. 2013;36(2):288–295. doi:10.1016/j.etap.2013.04.00423686009
   PubMed Web of Science ®Google Scholar
• GelliC, TarocchiM, AbenavoliL, Di RenzoL, GalliA, De LorenzoA. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23(17):3150–3162. doi:10.3748/wjg.v23.i17.315028533672
   PubMed Web of Science ®Google Scholar
• WenM, WuJ, LuoH, ZhangH. Galangin induces autophagy through upregulation of p53 in HepG2 cells. Pharmacology. 2012;89(5–6):247–255. doi:10.1159/00033704122507894
   PubMed Web of Science ®Google Scholar
• Madrigal-MatuteJ, CuervoAM. Regulation of liver metabolism by autophagy. Gastroenterology. 2016;150(2):328–339. doi:10.1053/j.gastro.2015.09.04226453774
   PubMed Web of Science ®Google Scholar
• KomatsuM. Liver autophagy: physiology and pathology. J Biochem. 2012;152(1):5–15. doi:10.1093/jb/mvs05922661765
   PubMed Web of Science ®Google Scholar
• SinhaRA, FarahBL, SinghBK, et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology. 2014;59(4):1366–1380. doi:10.1002/hep.2666723929677
   PubMed Web of Science ®Google Scholar
• YangL, LiP, FuS, CalayES, HotamisligilGS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467–478. doi:10.1016/j.cmet.2010.04.00520519119
   PubMed Web of Science ®Google Scholar
• WuY, WangX, GuoH, et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy. 2013;9(4):595–603. doi:10.4161/auto.2364123412639
   PubMed Web of Science ®Google Scholar
• LiX, WangY, XiongY, et al. Galangin induces autophagy via deacetylation of LC3 by SIRT1 in HepG2 cells. Sci Rep. 2016;6:30496. doi:10.1038/srep3049627460655
   PubMed Web of Science ®Google Scholar
• LiuY, ZhouX, XiaoY, et al. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway. J Endocrinol. 2020;245(3):411–423. doi:10.1530/JOE-20-003332252024
   PubMed Web of Science ®Google Scholar
• YoussryS, KamelMA. Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease. Eur Cytokine Netw. 2019;30(4):135–143. doi:10.1684/ecn.2019.043732096475
   PubMed Web of Science ®Google Scholar
• MussoG, GambinoR, CassaderM. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1–26. doi:10.1016/j.plipres.2008.08.00118824034
   PubMed Web of Science ®Google Scholar
• Miquilena-ColinaME, Lima-CabelloE, Sanchez-CamposS, et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 2011;60(10):1394–1402. doi:10.1136/gut.2010.22284421270117
   PubMed Web of Science ®Google Scholar
• CohenJC, HortonJD, HobbsHH. Human fatty liver disease: old questions and new insights. Science. 2011;332(6037):1519–1523. doi:10.1126/science.120426521700865
   PubMed Web of Science ®Google Scholar
• AoyamaT, PetersJM, IritaniN, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem. 1998;273(10):5678–5684. doi:10.1074/jbc.273.10.56789488698
   PubMed Web of Science ®Google Scholar
• WootenJS, NickTN, SeijaA, PooleKE, StoutKB. High-fructose intake impairs the hepatic hypolipidemic effects of a high-fat fish-oil diet in C57BL/6 mice. J Clin Exp Hepatol. 2016;6(4):265–274. doi:10.1016/j.jceh.2016.09.00128003715
   PubMedGoogle Scholar
• JanevskiM, RatnayakeS, SiljanovskiS, McGlynnMA, Cameron-SmithD, LewandowskiP. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat. Food Funct. 2012;3(2):141–149. doi:10.1039/C1FO10111K22159273
   PubMed Web of Science ®Google Scholar